News - Herceptin

Filter

Current filters:

Herceptin

Popular Filters

28 to 36 of 36 results

Clinical gold-standard treatment for metastatic first-line HER2-positive breast cancer in 2015

05-02-2012

Based on clinical data and the opinions of interviewed thought leaders, Roche/Genentech/Chugai’s…

Asia-PacificEuropeHerceptinMarkets & MarketingNorth AmericaOncologyPharmaceuticalRocheTaxotere

Roche signs up to $490 million accord with PTC Thera for SMA program; and deal with Galena

30-11-2011

Swiss drug major Roche (ROG: SIX) has signed a licensing agreement with privately-held US firm PTC Therapeutics…

Galena BioPharmaHerceptinLicensingNeuVaxOncologyPharmaceuticalPTC TherapeuticsRare diseasesResearchRoche

Glycotope enrolls first patient for “biobetter” of Roche cancer drug Herceptin

20-09-2011

Berlin, Germany-based glycomics specialist Glycotope GmbH says it has enrolled the first patients in…

BiotechnologyGenericsGlycotopeHerceptinOncologyResearchRochetrastuzumab

UK NICE says benefits of breast cancer drugs Tyverb and Herceptin still unproven

03-07-2011

In a draft guidance issued last Friday, the UK’s drug watchdog, the National Institute for Health…

GlaxoSmithKlineHerceptinOncologyPharmaceuticalPricingRegulationRocheTyverb

Roche to start production of Herceptin in Russia

23-06-2011

R-Farm, one of Russia’s largest drugs’ distributors, has reached an agreement with Roche (ROG:…

EuropeHerceptinLicensingMarkets & MarketingOncologyPharmaceuticalR-FarmRoche

Satisfaction with gastric cancer treatment options remains low, GfK study notes

19-05-2011

In just over a month following the US Food and Drug Administration’s approval last fall of Swiss…

HerceptinMarkets & MarketingOncologyPharmaceuticalRoche

New treatment avenue identified for breast cancer

19-05-2011

Researchers at the CHUM Research Centre (CRCHUM) and the Peter MacCallum Cancer Centre in Australia have…

HerceptinOncologyPharmaceuticalResearchRoche

28 to 36 of 36 results

Back to top